Coagulation and Fibrinolysis Parameters in Type 2 Diabetic Patients with and without Diabetic Vascular Complications

Publisher： Karger

E-ISSN： 1423-0151|14|1|22-30

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.14, Iss.1, 2004-12, pp. : 22-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications

By  

Medical Principles and Practice, Vol. 18, Iss. 4, 2009-06 ,pp. : 266-271

Karger

Access to resources Recommend Favorite

Genes for systemic vascular complications are differentially expressed in the livers of Type 2 diabetic patients

By Takamura T.   Sakurai M.   Ota T.   Ando H.   Honda M.   Kaneko S.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 638-647

Springer Publishing Company

Access to resources Recommend Favorite

Insulin resistance and metabolic parameters in type 2 diabetic patients

By Metzler W.   Fischer S.   Kohler C.   Pistrosch F.   Kindel B.   Hanefeld M.  

European Journal of Internal Medicine, Vol. 13, Iss. 2, 2002-03 ,pp. : 108-114

Elsevier

Access to resources Recommend Favorite

Circulating monocyte chemoattractant protein-1 links to diabetic retinopathy in type 2 diabetic patients without renal dysfunction

By Morita Shuhei  

Diabetology International, Vol. 1, Iss. 2, 2010-12 ,pp. : 78-82

Springer Publishing Company

Access to resources Recommend Favorite

Role of Endothelin in Diabetic Vascular Complications

By Lam H-C.  

Endocrine Journal, Vol. 14, Iss. 3, 2001-04 ,pp. : 277-284

Humana Press, Inc

Access to resources Recommend Favorite